Attached files

file filename
10-K - Artemis Therapeutics, Inc.zk1007974.htm
EX-31.1 - Artemis Therapeutics, Inc.exhibit_31-1.htm
EX-32.1 - Artemis Therapeutics, Inc.exhibit_32-1.htm
EX-31.2 - Artemis Therapeutics, Inc.exhibit_31-2.htm

                                                                    EXHIBIT 23.1

             INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT

We consent to the incorporation by reference in the Registration Statement No.
333-130168 on Form S-8 of our report dated February 26, 2010 (which report
expresses an unqualified opinion), appearing in the Annual Report on Form 10-K
of InkSure Technologies Inc. for the year ended December 31, 2009.

Brightman Almagor & Co.
Certified Public Accountants,
A member firm of  Deloitte Touche Tohmatsu

Tel Aviv, Israel
February 25, 2010